BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15004605)

  • 1. [Thymectomy and muscle antibodies in myasthenia gravis].
    Romi F; Gilhus NE; Aarli JA
    Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
    Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.
    Romi F; Kristoffersen EK; Aarli JA; Gilhus NE
    J Neuroimmunol; 2005 Jan; 158(1-2):191-4. PubMed ID: 15589053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
    Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
    Eur Neurol; 2003; 49(4):210-7. PubMed ID: 12736536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titin and ryanodine receptor antibodies in myasthenia gravis.
    Skeie GO; Aarli JA; Gilhus NE
    Acta Neurol Scand Suppl; 2006; 183():19-23. PubMed ID: 16637922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
    Skeie GO; Romi F
    Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
    Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.
    Romi F; Aarli JA; Gilhus NE
    Eur J Neurol; 2007 Jun; 14(6):617-20. PubMed ID: 17539937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.
    Romi F; Skeie GO; Vedeler C; Aarli JA; Zorzato F; Gilhus NE
    J Neuroimmunol; 2000 Nov; 111(1-2):169-76. PubMed ID: 11063835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of infrasternal mediastinoscopic thymectomy in myasthenia gravis.
    Murai H; Uchiyama A; Mei FJ; Kojima M; Kira J
    J Neurol Sci; 2009 Dec; 287(1-2):185-7. PubMed ID: 19726063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis.
    Somnier FE
    Dan Med Bull; 1996 Feb; 43(1):1-10. PubMed ID: 8906977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsternal thymectomy for myasthenia gravis: surgical outcome.
    Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
    Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.